Diagnósticos da América S.A. (BOVESPA:DASA3) agreed to acquire AmeriMed American Hospitals on January 13, 2022. The superintendent of Brazilian antitrust body Cade has approved medical diagnostic firm Dasa's acquisition of control in the Grupo Marimed hospital group, without restrictions.